SCHEMBL31423005

SCHEMBL31423005

NC(=O)c1cccc2ccc(=O)[nH]c12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 1/20 0.59
CA12 O43570 4/20 0.53
CA9 Q16790 4/20 0.53
AURKA O14965 2/20 0.51
PLK4 O00444 1/20 0.51
CHEK1 O14757 1/20 0.51
DAPK3 O43293 1/20 0.51
MAP4K4 O95819 1/20 0.51
CSF1R P07333 1/20 0.51
RET P07949 1/20 0.51
FGFR1 P11362 1/20 0.51
PDGFRA P16234 1/20 0.51
LTK P29376 1/20 0.51
KDR P35968 1/20 0.51
MAP2K2 P36507 1/20 0.51
FLT3 P36888 1/20 0.51
CSNK1A1 P48729 1/20 0.51
PRKX P51817 1/20 0.51
CDK5 Q00535 1/20 0.51
MAP2K1 Q02750 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4917314 0.84 KEAP1 (0.58) CA12CA9KDM4EALDH1A1ALOX15
SCHEMBL9293801 0.78 CA12 (0.53) PDPK1CA12CA9KDM4EALDH1A1
SCHEMBL9293777 0.78 CHEK1 (0.54) CA12CA9CHEK1CLK4DYRK1B
SCHEMBL31423196 0.78 PLK1 (0.51) CA12CA9CHEK1CLK4DYRK1B
SCHEMBL31423274 0.77 PDPK1 (0.53) PDPK1AURKAPLK4CHEK1DAPK3
SCHEMBL29567411 0.74 PDPK1 (1.00) PDPK1AURKAPLK4CHEK1DAPK3
SCHEMBL1651352 0.74 PDPK1 (1.00) PDPK1AURKAPLK4CHEK1DAPK3
SCHEMBL29696398 0.74 PDPK1 (0.53) PDPK1AURKAPLK4CHEK1DAPK3
SCHEMBL19857562 0.74 PDPK1 (0.53) PDPK1AURKAPLK4CHEK1DAPK3
SCHEMBL3224071 0.73 CA12 (0.60) CA12CA9AURKAPARP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025085233-A1 NOVEL DERIVATIVES OF QUINOLINONES, AND COMPOSITIONS AND METHODS THEREOF ENSEM THERAPEUTICS, INC. (US) 2025-04-24 WO disclosed